{"answer":{"query":"januvia","resolved_as":"name","packages":19,"applications":["NDA021995"],"identity":{"application_numbers":["NDA021995"],"marketing_categories":["NDA"],"labelers":[{"text":"MERCK SHARP & DOHME LLC","untrusted":true},{"text":"MERCK & CO., INC.","untrusted":true}],"dosage_forms":[{"text":"TABLET, FILM COATED","untrusted":true}],"marketing_start":{"earliest":"2006-10-16","latest":"2012-10-12","packages_with_a_start_date":13}},"price":{"median_negotiated_over_nadac":0.371,"packages_compared":13,"packages_listed":19,"negotiated_price_ends":null,"rows":[{"ndc":"00006011201","name":{"text":"JANUVIA 50MG TABLET INNER PACK","untrusted":true},"class":"B","nadac_per_unit":10.54591,"negotiated_per_unit":3.907885,"ratio":0.371,"ful_per_unit":null},{"ndc":"00006011228","name":{"text":"JANUVIA 50MG TABLET 100UU","untrusted":true},"class":"B","nadac_per_unit":10.54591,"negotiated_per_unit":3.907885,"ratio":0.371,"ful_per_unit":null},{"ndc":"00006011231","name":{"text":"JANUVIA 50MG TABLETS 30UU","untrusted":true},"class":"B","nadac_per_unit":10.54591,"negotiated_per_unit":3.907885,"ratio":0.371,"ful_per_unit":null},{"ndc":"00006011254","name":{"text":"JANUVIA 50MG TABLETS 90UU","untrusted":true},"class":"B","nadac_per_unit":10.54591,"negotiated_per_unit":3.907885,"ratio":0.371,"ful_per_unit":null},{"ndc":"00006022101","name":{"text":"JANUVIA 25MG TABLET 100UU INNER PACK","untrusted":true},"class":"B","nadac_per_unit":10.54117,"negotiated_per_unit":3.907885,"ratio":0.371,"ful_per_unit":null},{"ndc":"00006022128","name":{"text":"JANUVIA 25MG TABLET 100UU","untrusted":true},"class":"B","nadac_per_unit":10.54117,"negotiated_per_unit":3.907885,"ratio":0.371,"ful_per_unit":null},{"ndc":"00006022131","name":{"text":"JANUVIA 25MG TABLETS 30UU","untrusted":true},"class":"B","nadac_per_unit":10.54117,"negotiated_per_unit":3.907885,"ratio":0.371,"ful_per_unit":null},{"ndc":"00006022154","name":{"text":"JANUVIA 25MG TABLETS 90UU","untrusted":true},"class":"B","nadac_per_unit":10.54117,"negotiated_per_unit":3.907885,"ratio":0.371,"ful_per_unit":null},{"ndc":"00006027701","name":{"text":"JANUVIA 100MG TABLET INNER PACK","untrusted":true},"class":"B","nadac_per_unit":10.55001,"negotiated_per_unit":3.907885,"ratio":0.37,"ful_per_unit":null},{"ndc":"00006027702","name":{"text":"JANUVIA 100 MG TABLET 30 CT CALENDAR PACK","untrusted":true},"class":null,"nadac_per_unit":null,"negotiated_per_unit":3.907885,"ratio":null,"ful_per_unit":null},{"ndc":"00006027714","name":{"text":"","untrusted":true},"class":null,"nadac_per_unit":null,"negotiated_per_unit":3.907885,"ratio":null,"ful_per_unit":null},{"ndc":"00006027727","name":{"text":"","untrusted":true},"class":null,"nadac_per_unit":null,"negotiated_per_unit":3.907885,"ratio":null,"ful_per_unit":null},{"ndc":"00006027728","name":{"text":"JANUVIA 100MG TAB 100UD","untrusted":true},"class":"B","nadac_per_unit":10.55001,"negotiated_per_unit":3.907885,"ratio":0.37,"ful_per_unit":null},{"ndc":"00006027730","name":{"text":"","untrusted":true},"class":null,"nadac_per_unit":null,"negotiated_per_unit":3.907885,"ratio":null,"ful_per_unit":null},{"ndc":"00006027731","name":{"text":"JANUVIA 100MG TABLET 30UU","untrusted":true},"class":"B","nadac_per_unit":10.55001,"negotiated_per_unit":3.907885,"ratio":0.37,"ful_per_unit":null},{"ndc":"00006027733","name":{"text":"JANUVIA TABLET 100 MG","untrusted":true},"class":null,"nadac_per_unit":null,"negotiated_per_unit":3.907885,"ratio":null,"ful_per_unit":null},{"ndc":"00006027754","name":{"text":"JANUVIA 100MG TABLET 90UU","untrusted":true},"class":"B","nadac_per_unit":10.55001,"negotiated_per_unit":3.907885,"ratio":0.37,"ful_per_unit":null},{"ndc":"00006027774","name":{"text":"","untrusted":true},"class":null,"nadac_per_unit":null,"negotiated_per_unit":3.907885,"ratio":null,"ful_per_unit":null},{"ndc":"00006027782","name":{"text":"JANUVIA 100MG TAB 1000UD","untrusted":true},"class":"B","nadac_per_unit":10.55001,"negotiated_per_unit":3.907885,"ratio":0.37,"ful_per_unit":null}],"negotiated_scheduled":{"thirty_day":116.06,"effective":"2027-01-01"}},"generic_entry":[{"application":"NDA021995","date":"2027-05-24","reading":"upper bound from listed dates, not a forecast","basis":"latest of all listed patent and exclusivity expiries in this Orange Book edition; an upper bound from listed dates only, not a forecast of launch (litigation, settlements, delisting, tentative approvals and 180-day status are not modelled)","driver":{"kind":"patent","ref":"7326708*PED","productNo":"002"},"latest_patent_expiry":"2027-05-24","latest_exclusivity_expiry":"NOT_PROVIDED","dated_barriers":6,"undated_barriers":0,"orange_book_edition":"2026-09","patents_listed":1,"exclusivities_listed":0,"fact_id":"537311e93b87d41a2f932a95"}],"label_history":{"events_total":35,"non_cmc_events":28,"counts_by_class":{"LABELING":20,"EFFICACY":8},"cmc_events":7,"recent_non_cmc_events":[{"application":"NDA021995","submission_no":50,"class_code":"LABELING","class_description":{"text":"Labeling","untrusted":true},"status":"AP","date":"2022-06-21","documents":[{"type":"Letter","date":"2022-06-22","link":{"text":"https://www.accessdata.fda.gov/drugsatfda_docs/appletter/2022/021995Orig1s050, 022044Orig1s052, 202270Orig1s026ltr.pdf","untrusted":true}},{"type":"Label","date":"2022-06-24","link":{"text":"http://www.accessdata.fda.gov/drugsatfda_docs/label/2022/021995s050lbl.pdf","untrusted":true}}],"fact_id":"786d8e5b068c995d0ad6f753"},{"application":"NDA021995","submission_no":47,"class_code":"EFFICACY","class_description":{"text":"Efficacy","untrusted":true},"status":"AP","date":"2020-12-04","documents":[{"type":"Label","date":"2020-12-04","link":{"text":"http://www.accessdata.fda.gov/drugsatfda_docs/label/2020/021995s047lbl.pdf","untrusted":true}},{"type":"Letter","date":"2020-12-08","link":{"text":"http://www.accessdata.fda.gov/drugsatfda_docs/appletter/2020/021995Orig1s047; 022044Orig1s048; 202270Orig1s022ltr.pdf","untrusted":true}}],"fact_id":"84dd6cdedbc88c7ce10ca0e2"},{"application":"NDA021995","submission_no":45,"class_code":"EFFICACY","class_description":{"text":"Efficacy","untrusted":true},"status":"AP","date":"2019-08-12","documents":[{"type":"Letter","date":"2019-08-13","link":{"text":"http://www.accessdata.fda.gov/drugsatfda_docs/appletter/2019/021995Orig1s045, 202270Orig1s019, 022044Orig1s046.ltr.pdf","untrusted":true}},{"type":"Label","date":"2019-08-13","link":{"text":"http://www.accessdata.fda.gov/drugsatfda_docs/label/2019/021995s045lbl.pdf","untrusted":true}}],"fact_id":"2a7e506eaa1300a3a8fb5e69"},{"application":"NDA021995","submission_no":46,"class_code":"LABELING","class_description":{"text":"Labeling","untrusted":true},"status":"AP","date":"2019-07-01","documents":[{"type":"Letter","date":"2019-07-02","link":{"text":"http://www.accessdata.fda.gov/drugsatfda_docs/appletter/2019/021995Orig1s046, 022044Orig1s047, 202270Orig1s020ltr.pdf","untrusted":true}},{"type":"Label","date":"2019-07-09","link":{"text":"http://www.accessdata.fda.gov/drugsatfda_docs/label/2019/021995s046lbl.pdf","untrusted":true}}],"fact_id":"0eb3d3d9ed5f26f4643b4002"},{"application":"NDA021995","submission_no":42,"class_code":"LABELING","class_description":{"text":"Labeling","untrusted":true},"status":"AP","date":"2018-02-09","documents":[{"type":"Label","date":"2018-02-12","link":{"text":"http://www.accessdata.fda.gov/drugsatfda_docs/label/2018/021995s042lbl.pdf","untrusted":true}},{"type":"Letter","date":"2018-02-14","link":{"text":"http://www.accessdata.fda.gov/drugsatfda_docs/appletter/2018/021995Orig1s042,022044s043,202270Orig1s018ltr.pdf","untrusted":true}}],"fact_id":"41e31166a1819f621f5168e7"}],"note":"a dated list of FDA supplements and their classes, not a reading of what changed in the label"},"substitution":{"products_total":3,"te_code_counts":{"AB":3},"marketing_status_counts":{"Prescription":3},"meaning":"raw FDA codes; the therapeutic equivalence code says whether FDA rates a generic as substitutable, and what that means for a given prescription is for a pharmacist or prescriber","products":[{"application":"NDA021995","product_no":"003","te_code":"AB","marketing_status":"Prescription","drug_name":{"text":"JANUVIA","untrusted":true},"form":{"text":"TABLET;ORAL","untrusted":true},"strength":{"text":"EQ 100MG BASE","untrusted":true}},{"application":"NDA021995","product_no":"001","te_code":"AB","marketing_status":"Prescription","drug_name":{"text":"JANUVIA","untrusted":true},"form":{"text":"TABLET;ORAL","untrusted":true},"strength":{"text":"EQ 25MG BASE","untrusted":true}},{"application":"NDA021995","product_no":"002","te_code":"AB","marketing_status":"Prescription","drug_name":{"text":"JANUVIA","untrusted":true},"form":{"text":"TABLET;ORAL","untrusted":true},"strength":{"text":"EQ 50MG BASE","untrusted":true}}]},"supply":{"fda_shortage_status_counts":{},"packages_with_a_termination_date":2,"next_package_termination_dates":[],"packages_with_future_termination_date":0,"termination_meaning":"manufacturer-reported last-lot expiry or withdrawal date of one package; other packages and generics can remain"},"trials":{"attribution":"Source: ClinicalTrials.gov","modification_statement":"OmniRx has summarized and trimmed this ClinicalTrials.gov data.","not_an_offer":"A recruiting trial listing is not an offer of free drug and not medical advice; enrollment is decided by the study team.","ingredients":[{"ingredient":{"text":"SITAGLIPTIN","untrusted":true},"recruiting_interventional_count":13,"not_yet_recruiting_count":5,"by_phase":{"PHASE1/PHASE2":3,"PHASE4":4,"PHASE2":2,"PHASE1":2,"PHASE3":1,"NA":1},"registry_processing_date":"2026-11-06T10:00:05","modifications":"Counts and phase tallies computed here from the full recruiting result set; trials trimmed to the 25 most recently updated, conditions to 3, countries to 10 distinct; no text edited.","recent_trials":[{"nct_id":"NCT07675174","title":{"text":"PTCy, Bortezomib and Sitagliptin for Prevention of GvHD Following Allogeneic HSCT","untrusted":true},"phase":["PHASE1","PHASE2"],"sponsor":{"text":"Northwell Health","untrusted":true},"status":"RECRUITING","last_update_posted":"2026-11-06","start_date":"2026-08-14","link":{"text":"https://clinicaltrials.gov/study/NCT07675174","untrusted":true}},{"nct_id":"NCT07436663","title":{"text":"Comparative Study Between (SGLT-2i) and (DPP-4i) in the Prevention of DIC","untrusted":true},"phase":["PHASE4"],"sponsor":{"text":"Tanta University","untrusted":true},"status":"RECRUITING","last_update_posted":"2026-10-15","start_date":"2026-02-01","link":{"text":"https://clinicaltrials.gov/study/NCT07436663","untrusted":true}},{"nct_id":"NCT07003542","title":{"text":"A Phase 2 and Pharmacodynamic Study of Sitagliptin in Patients With Progressive Grade 4 Gliomas","untrusted":true},"phase":["PHASE2"],"sponsor":{"text":"Case Comprehensive Cancer Center","untrusted":true},"status":"RECRUITING","last_update_posted":"2026-08-06","start_date":"2026-03-16","link":{"text":"https://clinicaltrials.gov/study/NCT07003542","untrusted":true}},{"nct_id":"NCT07634380","title":{"text":"Sitagliptin With Pembro in RCC and Melanoma","untrusted":true},"phase":["PHASE1"],"sponsor":{"text":"Fernando Maciel Barbosa","untrusted":true},"status":"RECRUITING","last_update_posted":"2026-07-30","start_date":"2026-05-14","link":{"text":"https://clinicaltrials.gov/study/NCT07634380","untrusted":true}},{"nct_id":"NCT07717242","title":{"text":"Sun Yat-Sen Treatment Strategy for Enhancing Response in Muscle-invasive Bladder Cancer","untrusted":true},"phase":["PHASE2"],"sponsor":{"text":"Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University","untrusted":true},"status":"RECRUITING","last_update_posted":"2026-07-21","start_date":"2026-07-01","link":{"text":"https://clinicaltrials.gov/study/NCT07717242","untrusted":true}}],"fact_id":"99acef15d07396598d3ebc70"}]},"assistance_and_offers":{"programs_listing_this_drug":[{"name":{"text":"Merck Helps (Merck Patient Assistance Program)","untrusted":true},"type":"manufacturer","url":"https://www.merckhelps.com/","status":null,"needs_status_check":false,"has_offer":false}],"manufacturer_offers":[],"note":"A program that lists a drug has not decided anything about any person: each program decides who qualifies, and a status other than open means it may not take new patients. Offers change and expire; read each offer's source and stated end date. A price figure is what the page states, not a quote."},"spending":{"reported_under":{"generic":{"text":"Sitagliptin Phosphate","untrusted":true},"brand":{"text":"Januvia","untrusted":true}},"latest_year":2024,"series":[{"year":2020,"gross_spending_usd":3865087772.5,"claims":4664181,"beneficiaries":934686,"average_spending_per_claim_usd":828.67448166,"fact_id":"df065609d9abcec3a36b6b22"},{"year":2021,"gross_spending_usd":4059534112,"claims":4507803,"beneficiaries":934542,"average_spending_per_claim_usd":900.55712551,"fact_id":"cd5124d7f3c73af4e620e9aa"},{"year":2022,"gross_spending_usd":4097997364.9,"claims":4242641,"beneficiaries":884825,"average_spending_per_claim_usd":965.90717077,"fact_id":"5acae974326b1bfd089609bf"},{"year":2023,"gross_spending_usd":4090836820.7,"claims":4029094,"beneficiaries":843391,"average_spending_per_claim_usd":1015.3242443,"fact_id":"c4c55dd2cfe3c5a459766091"},{"year":2024,"gross_spending_usd":3807854661.8,"claims":4027317,"beneficiaries":828288,"average_spending_per_claim_usd":945.50656474,"fact_id":"2f031497a4b69005a22b0345"}],"rebate_caveat":"CMS's dataset states spending is gross drug cost and does not reflect manufacturers' rebates or other price concessions.","not_a_patient_price":"Spending is the total paid by Medicare, plans and beneficiaries for the drug's claims, not what a patient pays.","meaning":"a drug-level aggregate of Medicare Part D claims for all manufacturers combined; not a formulary, not coverage","source":{"dataset":{"text":"data-year-2024, modified 2026-06-25","untrusted":true},"link":{"text":"https://data.cms.gov/summary-statistics-on-use-and-payments/medicare-medicaid-spending-by-drug/medicare-part-d-spending-by-drug","untrusted":true}}},"rems":{"programs":[{"application":"NDA021995","program":{"text":"Januvia","untrusted":true},"rems_id":"206","in_force":false,"released":true,"moved_to_shared_system":false,"has_etasu":false,"program_date":"2010-02-26","last_modified":"2011-04-14","source_page":"https://www.accessdata.fda.gov/scripts/cder/rems/index.cfm?event=IndvRemsDetails.page&REMS=206","other_programs":0,"read_on":"2026-11-07T20:05:28.959Z","fact_id":"3636464e7c4c0f48db454fed"}],"reading":"what the FDA REMS@FDA files tie to the application on the read date; it does not say which prescribers or pharmacies take part or whether a patient needs the program"},"orphan_designation":{"ingredients":[{"ingredient":{"text":"sitagliptin","untrusted":true},"designation_count":1,"approved_count":0,"recent":[{"designated":"2026-01-15","use":{"text":"treatment of Duchenne muscular dystrophy","untrusted":true},"status":"Designated","sponsor":{"text":"Revio Therapeutics LLP","untrusted":true},"approved":false}],"read_on":"2026-11-07T12:00:00.000Z","fact_id":"c9ce5fb095b9964e688521cd"}],"reading":"a designation is not an approval and not a statement that the drug treats the condition; status is the FDA database's own"},"medicaid_state_utilization":{"year":2025,"states_with_data":12,"all_states_medicaid_reimbursed_usd":323767.87,"all_states_medicaid_paid_prescriptions":904,"top_states":[{"state":"KS","medicaid_paid_prescriptions":131,"medicaid_reimbursed_usd":38394.17,"total_reimbursed_usd":38394.17,"packages":1,"covers":"all_record_types","fact_id":"d663921c616f26896c63ef6d"},{"state":"CO","medicaid_paid_prescriptions":96,"medicaid_reimbursed_usd":34993.9,"total_reimbursed_usd":36070.02,"packages":1,"covers":"fee_for_service_only","fact_id":"aa970cf3d8d9171f58eb927f"},{"state":"SC","medicaid_paid_prescriptions":73,"medicaid_reimbursed_usd":34889.79,"total_reimbursed_usd":34889.79,"packages":1,"covers":"fee_for_service_only","fact_id":"2c607328770abcaff2b91a41"},{"state":"OK","medicaid_paid_prescriptions":62,"medicaid_reimbursed_usd":33763.77,"total_reimbursed_usd":34811.71,"packages":1,"covers":"fee_for_service_only","fact_id":"2f86f9af46ef4cf7126cf718"},{"state":"NV","medicaid_paid_prescriptions":73,"medicaid_reimbursed_usd":31210.13,"total_reimbursed_usd":46712.54,"packages":1,"covers":"fee_for_service_only","fact_id":"b403a08cad929310df36b4c3"},{"state":"MN","medicaid_paid_prescriptions":90,"medicaid_reimbursed_usd":29044.15,"total_reimbursed_usd":29044.15,"packages":1,"covers":"fee_for_service_only","fact_id":"e6f551ad09044142d0ed7aee"},{"state":"VA","medicaid_paid_prescriptions":60,"medicaid_reimbursed_usd":25863.54,"total_reimbursed_usd":25863.54,"packages":1,"covers":"all_record_types","fact_id":"63fe0fe01944a9973abe8ebf"},{"state":"AL","medicaid_paid_prescriptions":65,"medicaid_reimbursed_usd":21645.29,"total_reimbursed_usd":22888.79,"packages":1,"covers":"all_record_types","fact_id":"f4b93c6592bc95bf91797c57"},{"state":"AK","medicaid_paid_prescriptions":86,"medicaid_reimbursed_usd":20359.74,"total_reimbursed_usd":20660.47,"packages":1,"covers":"fee_for_service_only","fact_id":"12e4acc5f4a4cc88b31e9ce8"},{"state":"MT","medicaid_paid_prescriptions":48,"medicaid_reimbursed_usd":18607.82,"total_reimbursed_usd":18607.82,"packages":1,"covers":"all_record_types","fact_id":"befc8c303ece00e9838adb35"}],"unlabelled_state_code_xx":null,"built_from_facts":12,"facts_fee_for_service_only":6,"older_year_facts_not_used":306,"dataset":"State Drug Utilization Data 2025","read_on":"2026-11-07T22:41:44.201Z","reading":"Medicaid prescriptions and reimbursement by state (CMS State Drug Utilization Data). Reimbursement is before manufacturer rebates: not a net cost, not a patient price. Suppressed managed-care cells make a state figure fee-for-service only. An absent state was suppressed or unreported, not zero.","receipts_note":"a receipt is held for the largest fact behind each state shown; every figure is a sum of the built_from_facts facts, each recomputable from its recorded input hash"}},"receipts":[{"fact_id":"25bd737e05c097bec4a8134d","field":"ndc.listing","entity":"ndc:00006011228"},{"fact_id":"935a1eaef4a7f4c73608121e","field":"ndc.listing","entity":"ndc:00006011231"},{"fact_id":"f21ed8bcd955b32be53e54d3","field":"ndc.listing","entity":"ndc:00006011254"},{"fact_id":"85cc0537fc7a89f7d6a21174","field":"ndc.nadac_price","entity":"ndc:00006011201"},{"fact_id":"18a6f6127a42cd5c8b2d232c","field":"ndc.nadac_price","entity":"ndc:00006011228"},{"fact_id":"9facb12793bb5d6081d2090d","field":"ndc.nadac_price","entity":"ndc:00006011231"},{"fact_id":"8832dec2a3e8f52545e4a0eb","field":"ndc.mfp","entity":"ndc:00006011201"},{"fact_id":"6ea6e678f624064cc595e393","field":"ndc.mfp","entity":"ndc:00006011228"},{"fact_id":"126fc4ea0ff68489d9e8d94c","field":"ndc.mfp","entity":"ndc:00006011231"},{"fact_id":"537311e93b87d41a2f932a95","field":"drug.generic_entry_earliest","entity":"application:NDA021995"},{"fact_id":"1875423fff5c26b59a243773","field":"drug.patent","entity":"application:NDA021995"},{"fact_id":"786d8e5b068c995d0ad6f753","field":"drug.label_event","entity":"application:NDA021995"},{"fact_id":"84dd6cdedbc88c7ce10ca0e2","field":"drug.label_event","entity":"application:NDA021995"},{"fact_id":"2a7e506eaa1300a3a8fb5e69","field":"drug.label_event","entity":"application:NDA021995"},{"fact_id":"0eb3d3d9ed5f26f4643b4002","field":"drug.label_event","entity":"application:NDA021995"},{"fact_id":"41e31166a1819f621f5168e7","field":"drug.label_event","entity":"application:NDA021995"},{"fact_id":"dc7fd8d7c2c7aab19db1f45b","field":"drug.te_code","entity":"application:NDA021995"},{"fact_id":"f75768505c36a4b01069811e","field":"drug.marketing_status","entity":"application:NDA021995"},{"fact_id":"234a67846468b4f751876014","field":"drug.te_code","entity":"application:NDA021995"},{"fact_id":"520bf3d8e8cf369d961393ba","field":"drug.marketing_status","entity":"application:NDA021995"},{"fact_id":"0422a8af26cb4d05dba4510c","field":"drug.te_code","entity":"application:NDA021995"},{"fact_id":"b0a346eccc314c5934c34c02","field":"drug.marketing_status","entity":"application:NDA021995"},{"fact_id":"99acef15d07396598d3ebc70","field":"drug.trial_access","entity":"drug:sitagliptin"},{"fact_id":"df065609d9abcec3a36b6b22","field":"drug.partd_spending","entity":"drug:sitagliptin-phosphate|januvia"},{"fact_id":"cd5124d7f3c73af4e620e9aa","field":"drug.partd_spending","entity":"drug:sitagliptin-phosphate|januvia"},{"fact_id":"5acae974326b1bfd089609bf","field":"drug.partd_spending","entity":"drug:sitagliptin-phosphate|januvia"},{"fact_id":"c4c55dd2cfe3c5a459766091","field":"drug.partd_spending","entity":"drug:sitagliptin-phosphate|januvia"},{"fact_id":"2f031497a4b69005a22b0345","field":"drug.partd_spending","entity":"drug:sitagliptin-phosphate|januvia"},{"fact_id":"3636464e7c4c0f48db454fed","field":"drug.rems","entity":"application:NDA021995"},{"fact_id":"c9ce5fb095b9964e688521cd","field":"drug.orphan_designation","entity":"drug:sitagliptin"},{"fact_id":"d663921c616f26896c63ef6d","field":"ndc.medicaid_state_utilization","entity":"ndc_state:00006011254:KS"},{"fact_id":"aa970cf3d8d9171f58eb927f","field":"ndc.medicaid_state_utilization","entity":"ndc_state:00006011254:CO"},{"fact_id":"2c607328770abcaff2b91a41","field":"ndc.medicaid_state_utilization","entity":"ndc_state:00006011254:SC"},{"fact_id":"2f86f9af46ef4cf7126cf718","field":"ndc.medicaid_state_utilization","entity":"ndc_state:00006022154:OK"},{"fact_id":"b403a08cad929310df36b4c3","field":"ndc.medicaid_state_utilization","entity":"ndc_state:00006022154:NV"},{"fact_id":"e6f551ad09044142d0ed7aee","field":"ndc.medicaid_state_utilization","entity":"ndc_state:00006022154:MN"},{"fact_id":"63fe0fe01944a9973abe8ebf","field":"ndc.medicaid_state_utilization","entity":"ndc_state:00006022128:VA"},{"fact_id":"f4b93c6592bc95bf91797c57","field":"ndc.medicaid_state_utilization","entity":"ndc_state:00006022154:AL"},{"fact_id":"12e4acc5f4a4cc88b31e9ce8","field":"ndc.medicaid_state_utilization","entity":"ndc_state:00006022131:AK"},{"fact_id":"befc8c303ece00e9838adb35","field":"ndc.medicaid_state_utilization","entity":"ndc_state:00006022154:MT"}],"as_of":{"newest_fact_retrieved_at":"2026-11-10T20:02:39.475Z"},"edition":{"id":"2026-11","merkleRoot":"006ab9a329709cbe7f56a0e1a7c4a02f897655cdfecf9ca34d199690095adcb6","factCount":212100,"manifestPresent":true},"licence":{"classes":["AMBER","GREEN"],"note":"Source records are public; this compilation is cited with attribution. See the provenance tool for each fact's licence label."},"unknown":[{"code":"NO_DATA","field":"recalls","reason":"no FDA enforcement report naming a package of these applications is recorded"},{"code":"NO_DATA","field":"policy","reason":"no Federal Register event in the edition names this drug or its programs"},{"code":"AMBIGUOUS","field":"spending","reason":"2 brand and generic name pairs match; the series shown is the one with the newest year and the largest spending"},{"code":"NO_DATA","field":"biologic_status","reason":"no biologic application of this drug has a Purple Book status in the edition (a drug that is not a biologic has none)"},{"code":"NO_DATA","field":"payment_limit","reason":"no HCPCS code whose NDC crosswalk names a package of these applications has a Part B payment limit in the edition"},{"code":"NO_DATA","field":"controlled_schedule","reason":"no DEA schedule entry matched this drug's ingredient in the edition"},{"code":"NO_DATA","field":"safety_communication","reason":"no FDA Drug Safety Communication names this drug's ingredient in the edition"}],"disclaimer":"OmniRx is a reference layer of dated public facts, not clinical advice and not a guarantee of price, coverage or eligibility. Each answer lists the facts it rests on."}